SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012738
Filing Date
2020-08-14
Accepted
2020-08-14 17:08:15
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20200630.htm   iXBRL 10-Q 1338382
2 EX-10.1 exhibit101-amendment2l.htm EX-10.1 6414
3 EX-10.2 exhibit102-amendment2d.htm EX-10.2 5917
4 EX-10.3 exhibit103-form147_716ba.htm EX-10.3 22793
5 EX-31.1 a2020q2-exhibit311.htm EX-31.1 16474
6 EX-31.2 a2020q2-exhibit312.htm EX-31.2 16483
7 EX-32.1 a2020q2-exhibit321.htm EX-32.1 9251
13 GRAPHIC exhibit103-form147_716ba001.jpg GRAPHIC 116556
14 GRAPHIC exhibit103-form147_716ba002.jpg GRAPHIC 129584
15 GRAPHIC exhibit103-form147_716ba003.jpg GRAPHIC 171019
16 GRAPHIC exhibit103-form147_716ba004.jpg GRAPHIC 127385
17 GRAPHIC exhibit103-form147_716ba005.jpg GRAPHIC 354305
18 GRAPHIC exhibit103-form147_716ba006.jpg GRAPHIC 165512
19 GRAPHIC exhibit103-form147_716ba007.jpg GRAPHIC 56445
  Complete submission text file 0001628280-20-012738.txt   6655246

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20200630.xsd EX-101.SCH 30919
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20200630_cal.xml EX-101.CAL 78977
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20200630_def.xml EX-101.DEF 121782
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20200630_lab.xml EX-101.LAB 386442
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20200630_pre.xml EX-101.PRE 247690
20 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20200630_htm.xml XML 777081
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 201106468
SIC: 2834 Pharmaceutical Preparations